Corneal Dose Reduction Using a Bismuth-Coated Latex Shield over the Eyes During Brain SPECT/CT.

This study aimed to determine whether a bismuth-coated latex shield (B-shield) could protect the eyes during brain SPECT/CT. A shield containing the heavy metal bismuth (equivalent to a 0.15-mm-thick lead shield) was placed over a cylindric phantom and the eyes of a 3-dimensional brain phantom filled with Tc solution. Subsequently, phantoms with and without the B-shield were compared using SPECT/CT. The CT parameters were 30-200 mA and 130 kV. The dose reduction achieved by the B-shield was measured using a pencil-shaped ionization chamber. The protective effects of the B-shield were determined by evaluating relative radioactivity concentration as well as artifacts (changes in CT number), linear attenuation coefficients, and coefficients of variation on SPECT images. The radiation doses with and without the B-shield were 0.14-0.77 and 0.36-1.93 mGy, respectively, and the B-shield decreased the average radiation dose by about 60%. The B-shield also increased the mean CT number, but only at locations just beneath the surface of the phantom. Streaks of higher density near the underside of the B-shield indicated beam hardening. Linear attenuation coefficients and the coefficients of variation did not significantly differ between phantoms with and without the B-shield, and the relative Tc radioactivity concentrations were not affected. The B-shield decreased the radiation dose without affecting estimated attenuation correction or radioactivity concentrations. Although surface artifacts increased with the B-shield, the quality of the SPECT images was acceptable. B-shields can help protect pediatric patients and patients with eye diseases who undergo SPECT imaging.